F. Ortuño

An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS‐R myelodysplastic syndrome patients into prognostically significant groups

F. Ortuño, A. Hurtado, T. Chen-Liang, 2018, International journal of laboratory hematology.